Does Seroquel Cause Thrombocytopenia?
Yes, Seroquel (quetiapine) can cause thrombocytopenia, though it is uncommon. This is a recognized hematological adverse effect that requires monitoring, particularly in patients with pre-existing risk factors.
Evidence from FDA Drug Labeling
The FDA-approved prescribing information for Seroquel explicitly addresses hematological risks 1:
- Patients with pre-existing low white blood cell count (WBC) or a history of drug-induced leukopenia/neutropenia should have their complete blood count (CBC) monitored while taking Seroquel 1
- Patients should be advised to contact their physician immediately if they develop fever, flu-like symptoms, sore throat, or any infection, as these could indicate very low WBC requiring discontinuation of Seroquel 1
Clinical Practice Guidelines
The American Academy of Child and Adolescent Psychiatry guidelines for schizophrenia treatment provide important context 2:
- Although primarily associated with clozapine, agranulocytosis can occur with any antipsychotic agent 2
- There is one unpublished report of a precipitous drop in both absolute neutrophil count (ANC) and platelets in a 12-year-old boy receiving quetiapine 2
- While the guidelines focus more on leukopenia, they acknowledge that hematological effects can extend to platelet counts 2
Case Reports and Research Evidence
Multiple case reports document quetiapine-associated thrombocytopenia:
A 2023 case report described thrombocytopenic purpura in a 19-year-old man with first-episode schizophrenia taking 400 mg/day quetiapine (co-prescribed with valproic acid), which resolved within two weeks after drug cessation 3
A 2015 case report documented the first Han-Chinese patient who developed both leucopenia and thrombocytopenia after taking 400 mg/day quetiapine for three and a half months 4. When quetiapine was reintroduced, leucopenia and decreased platelet count recurred by day six, but resolved after discontinuing quetiapine while maintaining valproic acid 4
A 2007 open-label study of quetiapine in borderline personality disorder reported two cases of transient thrombocytopenia among 29 patients 5
A 2005 case report described thrombotic thrombocytopenic purpura (TTP) associated with quetiapine on two separate occasions in the same patient, occurring within days of drug exposure 6. The FDA Adverse Event Reporting System had compiled three cases of TTP in patients on quetiapine as their sole medication 6
A 2021 case report documented quetiapine-induced thrombotic microangiopathy in a dialysis patient, with platelet count dropping from 13.2 × 10⁴/μL to 0.5 × 10⁴/μL 7. The platelet count recovered smoothly after quetiapine discontinuation 7
Clinical Implications and Monitoring
Baseline and periodic CBC monitoring is prudent when prescribing quetiapine, particularly in patients with:
- Pre-existing low WBC or platelet counts 1
- History of drug-induced hematological toxicity 1
- Concurrent use of other medications that may affect blood counts (such as valproic acid) 3, 4
The thrombocytopenia appears to be reversible upon drug discontinuation 3, 4, 6, 5, but can be life-threatening if not recognized early 3, 6.
Common Pitfalls
- Do not assume thrombocytopenia is solely due to co-prescribed medications (such as valproic acid) without considering quetiapine as a potential cause 3, 4
- Early recognition is critical as quetiapine-associated thrombocytopenia can progress rapidly and may present as TTP, requiring plasmapheresis 6
- Rechallenge with quetiapine after a thrombocytopenic episode can result in rapid recurrence (within 6 days), confirming drug causality 4